0001209191-21-024103.txt : 20210401
0001209191-21-024103.hdr.sgml : 20210401
20210401162000
ACCESSION NUMBER: 0001209191-21-024103
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210401
FILED AS OF DATE: 20210401
DATE AS OF CHANGE: 20210401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bergstrom Donald A
CENTRAL INDEX KEY: 0001709772
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39344
FILM NUMBER: 21798329
MAIL ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fusion Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001805890
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 270 LONGWOOD ROAD SOUTH
CITY: HAMILTON
STATE: A6
ZIP: L8P 0A6
BUSINESS PHONE: 289-799-0891
MAIL ADDRESS:
STREET 1: 270 LONGWOOD ROAD SOUTH
CITY: HAMILTON
STATE: A6
ZIP: L8P 0A6
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-01
0
0001805890
Fusion Pharmaceuticals Inc.
FUSN
0001709772
Bergstrom Donald A
C/O FUSION PHARMACEUTICALS, INC.
2 INTERNATIONAL PLACE, SUITE 2310
BOSTON
MA
02110
1
0
0
0
Stock Option (Right to Buy)
10.59
2021-04-01
4
A
0
34000
0.00
A
2031-04-01
Common Stock
34000
34000
D
The shares subject to this option shall vest and become exercisable in 36 substantially equal monthly installments starting on May 1, 2021.
/s/Maria Stahl as Attorney-in-Fact
2021-04-01